Comparing different dosing regimens of bevacizumab in the treatment of neovascular macular degeneration: study protocol for a randomised controlled trial. (2015)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s13063-015-0608-2
PubMed Identifier: 25873213
Publication URI: http://europepmc.org/abstract/MED/25873213
Type: Journal Article/Review
Volume: 16
Parent Publication: Trials
ISSN: 1745-6215